ScholarLens Back to search
1992•European Journal of CancerRequires access

Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours

Eva Tiensuu Janson, Håkan K. Ahlström, Torbjörn Andersson, Kjell E. Öberg

Open publisher page 132 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 132 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Octreotide, Medicine, Carcinoid syndrome, Carcinoid tumour, Alpha interferon, Interferon alfa, Gastroenterology, Internal medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours — Research Paper | ScholarLens